← Leaderboards
Eugene W Gerner
University Of Arizona
$5,028,555
Attributed
$5,028,555
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.2M · FY2005–12$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$35,060,930 · 9
By mechanism
P50$25,845,802 · 3
P01$7,303,181 · 2
R01$1,587,445 · 1
U19$243,752 · 1
R03$75,750 · 1
R13$5,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Arizona
Same institution · by research overlap
- M. Peter Lance$14,378,762
- David S Alberts$22,074,619
- Jennifer K. Barton$15,034,989
- Fred Kadlubar$724,236
- Elizabeth T Jacobs$4,207,163
Others in their field
Top investigators on “Chemoprevention”
- Charles A Coltman · Southwest Oncology Group$144,723,158
- Norman Wolmark · Nsabp Foundation, Inc.$110,141,959
- John Anthony Baron · Dartmouth College$61,176,184
- Fred M Gordin · Social And Scientific Systems, Inc.$50,695,408
- Caroline C Sigman · Ccs Associates, Inc.$26,419,788
- Jonathan White · Midwest Research Institute$24,635,824
Research focus
ChemopreventionCancer PreventionMalignant NeoplasmsGeneticPolyaminesTissuesOrnithine DecarboxylaseAllelesGenesMetabolismPreventionDl-Alpha-DifluoromethylornithineChemopreventive AgentAffectPreventiveColon CarcinomaSpermidine/Spermine N1-AcetyltransferaseHigh RiskNeoplasm /Cancer GeneticsCessation Of LifeIntestinesColorectal CancerBaseApoptosis
Grant awards (54)
GENETIC VARIABILITY AS PROGNOSTIC OR PREDICTIVE FACTORS IN COLORECTAL INTRAEPITHE$599,996
P50 · FY2012 · CA · contact PI
Specialized Program Research Excellence (SPORE) in Gastrointestinal Cancer$599,996
P50 · FY2012 · CA · contact PI
GENETIC VARIABILITY AS PROGNOSTIC OR PREDICTIVE FACTORS IN COLORECTAL INTRAEPITHE$88,491
P50 · FY2012 · CA · contact PI
Specialized Program Research Excellence (SPORE) in Gastrointestinal Cancer$88,491
P50 · FY2012 · CA · contact PI
Translational Control by eIF3f in Pancreatic Cancer$75,750
R03 · FY2012 · CA · contact PI
GENETIC VARIABILITY AS PROGNOSTIC OR PREDICTIVE FACTORS IN COLORECTAL INTRAEPITHE$366,968
P50 · FY2011 · CA · contact PI
Prevention of APC-Dependent Intestinal Carcinogenesis$278,293
R01 · FY2011 · CA · contact PI
Specialized Program Research Excellence (SPORE) in Gastrointestinal Cancer$109,409
P50 · FY2011 · CA · contact PI
Specialized Program Research Excellence (SPORE) in Gastrointestinal Cancer$2,300,000
P50 · FY2010 · CA · contact PI
GENETIC VARIABILITY AS PROGNOSTIC OR PREDICTIVE FACTORS IN COLORECTAL INTRAEPITHE$383,884
P50 · FY2010 · CA · contact PI
Prevention of APC-Dependent Intestinal Carcinogenesis$286,900
R01 · FY2010 · CA · contact PI
Specialized Program Research Excellence (SPORE) in Gastrointestinal Cancer$104,569
P50 · FY2010 · CA · contact PI
Prevention of APC-Dependent Intestinal Carcinogenesis$53,964
R01 · FY2010 · CA · contact PI
Specialized Program Research Excellence (SPORE) in Gastrointestinal Cancer$2,300,000
P50 · FY2009 · CA · contact PI
GENETIC VARIABILITY AS PROGNOSTIC OR PREDICTIVE FACTORS IN COLORECTAL INTRAEPITHE$374,784
P50 · FY2009 · CA · contact PI
Prevention of APC-Dependent Intestinal Carcinogenesis$286,900
R01 · FY2009 · CA · contact PI
Prevention of APC-Dependent Intestinal Carcinogenesis$53,802
R01 · FY2009 · CA · contact PI
Specialized Program Research Excellence (SPORE) in Gastrointestinal Cancer$50,798
P50 · FY2009 · CA · contact PI
Specialized Program Research Excellence (SPORE) in Gastrointestinal Cancer$2,300,000
P50 · FY2008 · CA · contact PI
GENETIC VARIABILITY AS PROGNOSTIC OR PREDICTIVE FACTORS IN COLORECTAL INTRAEPITHE$379,459
P50 · FY2008 · CA · contact PI
Prevention of APC-Dependent Intestinal Carcinogenesis$286,900
R01 · FY2008 · CA · contact PI
Prevention of APC-Dependent Intestinal Carcinogenesis$53,786
R01 · FY2008 · CA · contact PI
Specialized Program Research Excellence (SPORE) in Gastrointestinal Cancer$50,798
P50 · FY2008 · CA · contact PI
Specialized Program Research Excellence (SPORE) in Gastrointestinal Cancer$2,300,000
P50 · FY2007 · CA · contact PI
GENETIC VARIABILITY AS PROGNOSTIC OR PREDICTIVE FACTORS IN COLORECTAL INTRAEPITHE$340,296
P50 · FY2007 · CA · contact PI
Prevention of APC-Dependent Intestinal Carcinogenesis$286,900
R01 · FY2007 · CA · contact PI
CC: EVALUATION AND ADMINISTRATION$191,293
P50 · FY2007 · CA · contact PI
SPORE in Gastrointestinal Cancer$2,299,415
P50 · FY2006 · CA · contact PI
SPORE in Gastrointestinal Cancer$434,239
P50 · FY2006 · CA · contact PI
SPORE in Gastrointestinal Cancer$269,999
P50 · FY2006 · CA · contact PI
SPORE in Gastrointestinal Cancer$2,354,751
P50 · FY2005 · CA
Apoptosis in Colon Cancer Chemoprevention$1,404,831
P01 · FY2005 · CA
SPORE in Gastrointestinal Cancer$444,690
P50 · FY2005 · CA
Apoptosis in Colon Cancer Chemoprevention$35,071
P01 · FY2005 · CA
Gordon Research Conference of Polyamine$5,000
R13 · FY2005 · CA
SPORE in Gastrointestinal Cancer$2,356,575
P50 · FY2004 · CA
Apoptosis in Colon Cancer Chemoprevention$1,363,917
P01 · FY2004 · CA
SPORE in Gastrointestinal Cancer$448,418
P50 · FY2004 · CA
Apoptosis in Colon Cancer Chemoprevention$35,071
P01 · FY2004 · CA
SPORE in Gastrointestinal Cancer$2,378,411
P50 · FY2003 · CA
Apoptosis in Colon Cancer Chemoprevention$1,328,371
P01 · FY2003 · CA
Apoptosis in Colon Cancer Chemoprevention$27,818
P01 · FY2003 · CA
SPORE in Gastrointestinal Cancer$1,930,072
P50 · FY2002 · CA
Apoptosis in Colon Cancer Chemoprevention$1,313,750
P01 · FY2002 · CA
BIOCHEMICAL EFFECTORS OF GENE MUTATED IN COLON CANCER$130,479
P01 · FY2002 · CA
GENETIC VARIABILITY IN COLORECTAL NEOPLASIA$0
P50 · FY2002 · CA
Surrogate endpoint biomarkers in prostate cancer chemoprevention$0
U19 · FY2002 · CA
Surrogate endpoint biomarkers in prostate cancer chemoprevention$0
U19 · FY2002 · CA
Apoptosis in Colon Cancer Chemoprevention$1,280,347
P01 · FY2001 · CA
BIOCHEMICAL EFFECTORS OF GENE MUTATED IN COLON CANCER$130,479
P01 · FY2001 · CA
Surrogate endpoint biomarkers in prostate cancer chemoprevention$0
U19 · FY2001 · CA
Surrogate endpoint biomarkers in prostate cancer chemoprevention$243,752
U19 · FY2000 · CA
GENE MUTATIONS AND APOPTOSIS IN CANCER CHEMOPREVENTION$130,479
P01 · FY2000 · CA
APOPTOSIS IN COLON CANCER CHEMOPREVENTION$122,568
P01 · FY2000 · CA